The C20/20 Innovation Hub at McMaster University specializes in the development and commercialization of novel biomaterials and therapeutic approaches with a particular expertise in the ophthalmic space.

Our interdisciplinary team takes a global view of the translational pipeline, with expertise ranging from early stage chemistry through to preclinical validation. Our facilities are located at a world-class institution allowing us to provide tailored solutions maximizing your value.